Siegfried Holding AG (SFZN) - Financial and Strategic SWOT Analysis Review

Siegfried Holding AG (SFZN) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Siegfried Holding AG (Siegfried) is a contract development and manufacturing organization (CDMO). It specializes in the production of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. The company's services portfolio includes chemical development, analytical development, pilot manufacturing and scale-up and complex synthetic processing. Siegfried's product portfolio serves various therapeutic areas such as anesthetics, analgesics, and decongestants among others. The company's substances are available in a variety of formulations, including capsules, injectables, and lozenges among others. The company operates through manufacturing sites in Switzerland, the US, Malta, China, Germany, France, and Spain. Siegfried is headquartered in Zofingen, Aargau, Switzerland.

Siegfried Holding AG Key Recent Developments

Jul 10,2024: Siegfried Holding Appoints Marcel Imwinkelried as New CEO
Jul 10,2024: Ad hoc Media Release Jul 10, 2024Marcel Imwinkelried appointed as new CEO Read more
Apr 02,2024: Siegfried Announces Changes in Management Team
Feb 20,2024: Siegfried Continues to Deliver Profitable Growth

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Siegfried Holding AG - Key Facts
Siegfried Holding AG - Key Employees
Siegfried Holding AG - Key Employee Biographies
Siegfried Holding AG - Major Products and Services
Siegfried Holding AG - History
Siegfried Holding AG - Company Statement
Siegfried Holding AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Siegfried Holding AG - Business Description
Product Category: Drug Products
Overview
Performance
Product Category: Drug Substances
Overview
Performance
Siegfried Holding AG - Corporate Strategy
Siegfried Holding AG - SWOT Analysis
SWOT Analysis - Overview
Siegfried Holding AG - Strengths
Siegfried Holding AG - Weaknesses
Siegfried Holding AG - Opportunities
Siegfried Holding AG - Threats
Siegfried Holding AG - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Siegfried Holding AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jul 10, 2024: Siegfried Holding Appoints Marcel Imwinkelried as New CEO
Jul 10, 2024: Ad hoc Media Release Jul 10, 2024Marcel Imwinkelried appointed as new CEO Read more
Apr 02, 2024: Siegfried Announces Changes in Management Team
Feb 20, 2024: Siegfried Continues to Deliver Profitable Growth
Aug 17, 2023: Siegfried Delivers Strong Sales Growth And Profitability In First Half 2023
Mar 09, 2023: Siegfried opens global Development Center for Drug Products in Barcelona
Feb 22, 2023: Siegfried significantly increases sales and profits in 2022
Feb 18, 2023: Siegfried appoints Christian Dowdeswell as chief business officer drug substances
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Siegfried Holding AG, Key Facts
Siegfried Holding AG, Key Employees
Siegfried Holding AG, Key Employee Biographies
Siegfried Holding AG, Major Products and Services
Siegfried Holding AG, History
Siegfried Holding AG, Subsidiaries
Siegfried Holding AG, Joint Venture
Siegfried Holding AG, Key Competitors
Siegfried Holding AG, Ratios based on current share price
Siegfried Holding AG, Annual Ratios
Siegfried Holding AG, Annual Ratios (Cont...1)
Siegfried Holding AG, Annual Ratios (Cont...2)
Siegfried Holding AG, Interim Ratios
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Siegfried Holding AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Siegfried Holding AG, Performance Chart (2019 - 2023)
Siegfried Holding AG, Ratio Charts
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings